Masimo's smartSET FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes

Summary

Masimo's smartSET platform has received FDA clearance for its first-of-its-kind atrial fibrillation detection and AI-enabled opioid-induced respiratory depression detection, designed to enhance critical patient care